Weight loss drugs known as GLP-1s, including Ozempic, have a surprising impact on tobacco and alcohol habits. Studies indicate that GLP-1 users reduce their consumption of both substances while taking the medications. This observation suggests a potential positive effect on addictive behaviors, prompting further research to explore the causal link.